Benign infantile seizures associated with mild gastroenteritis
disease diseaseOn this page
Summary
Benign infantile seizures associated with mild gastroenteritis (MONDO:0015640) is a disease. A subtype of benign partial infantile seizures — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | benign infantile seizures associated with mild gastroenteritis |
| Mondo ID | MONDO:0015640 |
| Orphanet | 166305 |
| ICD-11 | 839512399 |
| SNOMED CT | 765756007 |
| UMLS | C4707564 |
| MedGen | 1647397 |
| GARD | 0020074 |
| Is cancer (heuristic) | no |
Disease family
Classification path: disease › human disease › disease by body system or component › nervous system disorder › central nervous system disorder › brain disorder › epilepsy › epilepsy syndrome › infantile epilepsy syndrome › benign partial infantile seizures › benign infantile seizures associated with mild gastroenteritis
Related subtypes (4): infantile convulsions and choreoathetosis, benign non-familial infantile seizures, benign infantile focal epilepsy with midline spikes and wave during sleep, benign familial infantile epilepsy
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.